Key Details
Price
$0.61Annual ROE
-32.08%Beta
1.54Events Calendar
Next earnings date:
Mar 7, 2025Recent quarterly earnings:
Nov 14, 2024Recent annual earnings:
Mar 7, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Oct 31, 1997Analyst ratings
Recent major analysts updates
Feb 11, 25 HC Wainwright & Co.
BuyFeb 11, 25 D. Boral Capital
BuyJan 31, 25 HC Wainwright & Co.
BuyJan 10, 25 Maxim Group
BuyJan 3, 25 D. Boral Capital
BuyDec 4, 24 HC Wainwright & Co.
BuyNov 20, 24 D. Boral Capital
BuyNov 18, 24 D. Boral Capital
BuyAug 20, 24 Craig-Hallum
BuyMay 6, 24 HC Wainwright & Co.
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Lineage Cell Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Lineage Cell Therapeutics?
- Does Lineage Cell Therapeutics pay dividends?
- What sector is Lineage Cell Therapeutics in?
- What industry is Lineage Cell Therapeutics in?
- What country is Lineage Cell Therapeutics based in?
- When did Lineage Cell Therapeutics go public?
- Is Lineage Cell Therapeutics in the S&P 500?
- Is Lineage Cell Therapeutics in the NASDAQ 100?
- Is Lineage Cell Therapeutics in the Dow Jones?
- When was Lineage Cell Therapeutics's last earnings report?
- When does Lineage Cell Therapeutics report earnings?
- Should I buy Lineage Cell Therapeutics stock now?
What is the ticker symbol for Lineage Cell Therapeutics?
The ticker symbol for Lineage Cell Therapeutics is NYSE American:LCTX
Does Lineage Cell Therapeutics pay dividends?
No, Lineage Cell Therapeutics does not pay dividends
What sector is Lineage Cell Therapeutics in?
Lineage Cell Therapeutics is in the Healthcare sector
What industry is Lineage Cell Therapeutics in?
Lineage Cell Therapeutics is in the Biotechnology industry
What country is Lineage Cell Therapeutics based in?
Lineage Cell Therapeutics is headquartered in United States
When did Lineage Cell Therapeutics go public?
Lineage Cell Therapeutics's initial public offering (IPO) was on March 5, 1992
Is Lineage Cell Therapeutics in the S&P 500?
No, Lineage Cell Therapeutics is not included in the S&P 500 index
Is Lineage Cell Therapeutics in the NASDAQ 100?
No, Lineage Cell Therapeutics is not included in the NASDAQ 100 index
Is Lineage Cell Therapeutics in the Dow Jones?
No, Lineage Cell Therapeutics is not included in the Dow Jones index
When was Lineage Cell Therapeutics's last earnings report?
Lineage Cell Therapeutics's most recent earnings report was on Nov 14, 2024
When does Lineage Cell Therapeutics report earnings?
The next expected earnings date for Lineage Cell Therapeutics is Mar 7, 2025
Should I buy Lineage Cell Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions